Mon 30 Nov 2009 | 4:00 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For GTC Biotherapeutics, Inc.

GTC Biotherapeutics, Inc. (GTCB.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector: Healthcare . industry: Biotechnology ยท View GTCB on other exchanges
As of  26 Nov 2009
1.00USD
Price Change
+0.00
Percent Change
+0.00%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Woloshen, Daniel 60 2002 Senior Vice President, General Counsel
Meade, Harry 62 2002 Senior Vice President - Research and Development
Scotland, Richard 53 -- Senior Vice President - Regulatory Affairs
Geraghty, James 54 2001 Director
Tuck, Alan 60 1993 Director
Bullock, Francis 72 1994 Director
McNamara, Pamela 51 2002 Director
Landine, Michael 55 2004 Director
Bechon, Christian 49 2006 Director
Heiden, William -- 2009 Director
Nguyen, Evelyne -- 2009 Director
Merot, Bertrand -- 2009 Director
Prost, Jean-Francois -- 2009 Director
Green, John 54 2002 Chief Financial Officer, Senior Vice President, Treasurer
Cox, Geoffrey 65 2001 Chairman of the Board, President, Chief Executive Officer